1. Pink Sheet

Rethinking What To Call The ‘Real World’

 
• By Sue Sutter

Stakeholders suggest a host of alternatives to what they see as the US FDA’s poor choice of words to describe studies intended to reflect actual clinical practice.

dictionary-thesaurus
The US FDA may want to rethink the terminology it uses for real-world studies. • Source: Shutterstock

The US Food and Drug Administration's terminology around real-world data and evidence is not going over well in the real world.

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Pink Sheet for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Clinical Trials

More from R&D